Cardlytics Inc (CDLX) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.00x

Cardlytics Inc (CDLX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $25.00K (capex $25.00K ) from operating cash flow of $13.01 Million. Explore Cardlytics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$25.00K
Capex + Investments

Operating Cash Flow

$13.01 Million
USD

Capital Expenditures

$25.00K
USD

Cardlytics Inc Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for Cardlytics Inc across 2 annual periods. Also explore how large is Cardlytics Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Cardlytics Inc (2019–2025)

Year-by-year capital reinvestment analysis for Cardlytics Inc. For live market cap and broader valuation context, see Cardlytics Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.05x $480.00K $9.29 Million $480.00K ▼ -97.3%
2019 1.92x $22.04 Million $11.46 Million $11.02 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow